New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
06:37 EDTSSYS, DDD, PRLB, VJET, MTLSPiper recommends buying 3D space following pullback
Piper Jaffray recommends using the recent weakness in shares of 3D printing companies as a buying opportunity, saying its Q2 reseller/industry survey yielded favorable feedback. The firm has Overweight ratings on 3D Systems (DDD), Materialise (MTLS), Materialise (MTLS), Proto Labs (PRLB) and Stratasys (SSYS). It has a Neutral rating on Voxeljet (VJET).
News For DDD;MTLS;PRLB;SSYS;VJET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
06:02 EDTMTLSMaterialise to acquire OrthoView Holding for GBP8.47M
Materialise announced the acquisition of UK-based OrthoView Holdings. Materialise acquired OrthoView for a cash payment of GBP8.47M and a possible additional earn out payment of up to GBP360,000. At completion, OrthoView had an estimated GBP1.2M in cash and cash equivalents on hand and no financial debt. The transaction, which was signed and closed simultaneously, is expected to be accretive to earnings per share within 12 months. The transaction combines the frontrunner in 2D templating on X-ray images with Materialise's market-leading position in 3D pre-operative planning tools to provide surgeons and hospitals a one-stop shop for surgical planning software tools and corresponding 3D printed medical devices.
06:01 EDTMTLSMaterialise acquires OrthoView for GBP 8.47M
Materialise announced the acquisition of UK-based OrthoView Holdings. Materialise acquired OrthoView for a cash payment of GBP 8.47M, and a possible additional earn out payment of up to GBP 0.36M. At completion, OrthoView had an estimated GBP 1.2M in cash and cash equivalents on hand and no financial debt. The transaction, which was signed and closed simultaneously, is expected to be accretive to earnings per share within 12 months. The transaction combines the frontrunner in 2D templating on X-ray images with Materialise's market-leading position in 3D pre-operative planning tools to provide surgeons and hospitals a one-stop shop for surgical planning software tools and corresponding 3D printed medical devices.
October 16, 2014
09:32 EDTPRLBProto Labs upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
09:31 EDTDDD3D Systems downgraded to Equal Weight from Overweight at Stephens
Subscribe for More Information
09:30 EDTSSYSStratasys upgraded to Overweight from Equal Weight at Stephens
October 15, 2014
07:32 EDTDDD, SSYSUBM Canon to hold a conference
PLASTEC Midwest Conference is being held in Chicago on October 15-16.
October 9, 2014
08:34 EDTMTLSMaterialise HeartPrint now listed as Class 1 medical device
Materialise NV has listed its 3D-printed cardiovascular HeartPrint models as a medical device in the U.S. and EU markets. After years of 3D printing anatomical models for educational and research purposes, the company addressed the need for models that can assist with diagnosing, planning and practicing complex cardiovascular procedures. This move strengthens the company's unique position in the market and is a natural extension of its Mimics Innovation Suite of software for medical image processing which has an existing 510(k) clearance and CE mark. By listing HeartPrint as a Class 1 medical device, the Company is able to add HeartPrint models to their offering for preoperative planning. The 3D-printed, patient-specific cardiovascular models are created from medical image data to provide cardiologists and surgeons with supplemental information to determine the best treatment for each unique patient.
October 8, 2014
07:31 EDTSSYS, DDDFDA to hold a public workshop
Subscribe for More Information
October 7, 2014
10:02 EDTMTLSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:19 EDTMTLSMaterialise initiated with a Buy at Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use